Page 4 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

Immunic Inc CEO Dr Daniel Vitt joined Proactive s Stephen Gunnion with news of the publication of extended data from the Phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting. ....

United States , Daniel Vitt , Stephen Gunnion , Neuroimmunology Neuroinflammation , American Academy Of Neurology , Immunic Inc ,

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United States , Neuroimmunology Neuroinflammation , Stephen Gunnion , Daniel Vitt , Immunic Inc , American Academy Of Neurology , American Academy ,

Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role

Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Stephen Gunnion , Daniel Vitt , International Day Of Immunology , Immunic Inc , International Day ,

Immunic (NASDAQ:IMUX) Downgraded to Sell at StockNews.com

StockNews.com cut shares of Immunic (NASDAQ:IMUX – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. Separately, Brookline Capital Management reaffirmed a buy rating and set a $10.00 target price on shares of Immunic in a research report on Friday, April 5th. View Our Latest Report […] ....

United States , Immunic Inc , Innovis Asset Management , Sweet Financial Partners , Acadian Asset Management , Sierra Summit Advisors , Free Report , Brookline Capital Management , Get Free Report , Asset Management , Financial Partners , Immunic Daily , Nasdaq Imux , Stocknews Com ,